Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,493 | 4,338 | 462 | 2,322 | 4,016 |
| Operating Income | -2,493 | -4,338 | -462 | -2,322 | -4,016 |
| Other Income | -2,045 | -2,304 | 9,557 | 4,404 | -2,155 |
| Pre-tax Income | -4,538 | -6,642 | 9,095 | 2,082 | -6,171 |
| Net Income Continuous | -4,538 | -6,642 | 9,095 | 2,082 | -6,171 |
| Net Income | $-4,538 | $-6,642 | $9,095 | $2,082 | $-6,171 |
| EPS Basic Total Ops | -0.39 | -0.60 | 2.28 | 12.85 | -11.24 |
| EPS Basic Continuous Ops | -0.39 | -0.60 | 2.28 | 12.95 | -11.24 |
| EPS Diluted Total Ops | -0.39 | -0.60 | 2.28 | 8.04 | -11.24 |
| EPS Diluted Continuous Ops | -0.39 | -0.60 | 2.28 | 8.09 | -11.24 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.60 | -0.09 | 3.75 | -11.51 |
| EBITDA(a) | $-2,474 | $-4,318 | $-443 | $-2,299 | $-3,991 |